Norges Bank Rapt Therapeutics, Inc. Transaction History

Norges Bank

  • $716 Trillion
  • Q3 2024

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$2.89 - $9.38 $289,867 - $940,814
100,300 New
100,300 $305,000
Q4 2023

Feb 09, 2024
BUY
$11.28 - $25.46 $1.13 Million - $2.55 Million
100,300 New
100,300 $2.49 Million
Q1 2023

May 15, 2024
BUY
$17.19 - $30.8 $1.69 Million - $3.02 Million
98,100 New
98,100 $1.8 Million
Q4 2022

Feb 14, 2023
BUY
$16.28 - $24.6 $4.2 Million - $6.35 Million
258,200 New
258,200 $5.11 Million
Q1 2022

May 09, 2022
SELL
$17.02 - $40.22 $1.68 Million - $3.97 Million
-98,600 Closed
0 $0
Q4 2021

Mar 09, 2022
BUY
$29.5 - $39.5 $2.91 Million - $3.89 Million
98,600 New
98,600 $3.62 Million
Q3 2021

Nov 14, 2022
BUY
$29.86 - $39.47 $7.19 Million - $9.5 Million
240,700 New
240,700 $7.47 Million
Q3 2021

Nov 05, 2021
SELL
$29.86 - $39.47 $1.38 Million - $1.83 Million
-46,300 Closed
0 $0
Q2 2021

Aug 15, 2022
BUY
$17.99 - $40.02 $832,936 - $1.85 Million
46,300 New
46,300 $1.47 Million
Q4 2020

Feb 10, 2021
SELL
$15.89 - $40.87 $476,700 - $1.23 Million
-30,000 Closed
0 $0
Q3 2020

Nov 12, 2021
BUY
$21.6 - $37.5 $648,000 - $1.13 Million
30,000 New
30,000 $966,000
Q1 2020

May 08, 2020
SELL
$11.86 - $48.86 $355,800 - $1.47 Million
-30,000 Closed
0 $0
Q4 2019

Mar 03, 2020
BUY
$12.3 - $30.78 $369,000 - $923,400
30,000 New
30,000 $828,000

Others Institutions Holding RAPT

# of Institutions
103
Shares Held
49.4M
Call Options Held
26.7K
Put Options Held
2.4K
View Full List

About RAPT Therapeutics, Inc.

RAPT Quotes by TradingView
  • Ticker RAPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,656,600
  • Market Cap $33.8M
  • Description
  • RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...
More about RAPT
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email